Taiwan FDA registration aa3efb7211008278fe2772d638c63a58
ATB STREP CLSI (12)
TW: 優必鏈球菌藥物敏感性試驗套組
Taiwan·Risk Class 2·MD·bioMérieux SA·Registered Dec 21, 2017 – Dec 21, 2022ExpiredRegistration details
- Analysis ID
- aa3efb7211008278fe2772d638c63a58
- License Form
- Ministry of Health Medical Device Import No. 030473
- Customs Code
- DHA05603047301
Company information
- Manufacturer
- bioMérieux SA
- Manufacturer Country
- France
- Authorized Representative
- Hong Kong Commercial Mérieux S.p.A. Taiwan Branch
Product details
- Intended Use
- This product is used for streptococcal and pneumococcal drug susceptibility test.
- Product Type (Level 1)
- C Immunology and microbiology devices
- Product Type (Level 2)
- C1640 Antimicrobial susceptibility test powder
- Import Information
- Imported from abroad
Dates and status
- Registration Date
- Dec 21, 2017
- Expiry Date
- Dec 21, 2022
About this record
Access comprehensive regulatory information for ATB STREP CLSI (12) in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number aa3efb7211008278fe2772d638c63a58 and manufactured by bioMérieux SA. The authorized representative in Taiwan is Hong Kong Commercial Mérieux S.p.A. Taiwan Branch.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices